An essential contribution by IFN-γ to CD8+ T cell-mediated rejection of pancreatic islet allografts

被引:79
作者
Diamond, AS
Gill, RG
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Dept Med, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Dept Immunol, Denver, CO 80262 USA
关键词
D O I
10.4049/jimmunol.165.1.247
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) T cells have long been considered to be the prototypical cytotoxic lymphocyte subpopulation. However, whether alloreactive CD8(+) T cells require traditional cytolytic pathways such as perforin and Fas ligand (FasL) to mediate graft rejection has been a controversial issue. In the present studies, we examined the role of varied effector pathways in CD8(+) T cell-mediated rejection of pancreatic islet allografts, Our goal was to systematically determine the relative requirements, if any, of perforin and Fast as well as the proinflammatory cytokine IFN-gamma in triggering graft destruction. To study CDS' T cell effector pathways independently of other lymphocyte populations, purified alloreactive CD8(+) T cells were adoptively transferred into severe combined immune-deficient (SCID) recipients bearing established islet allografts, Results indicate that to reject established islet allografts, primed CD8(+) T cells do not require the individual action of the conventional cytotoxic effecters perforin and Fas ligand, In contrast, the ability to produce IFN-gamma is critical for efficient CD8(+) T cell-mediated rejection of established islet allografts, Furthermore, alloreactive CD8(+) TCR transgenic T cells (2C) also show IFN-gamma dependence for mediating islet allograft rejection in vivo. We speculate from these results that the production of IFN-gamma by alloreactive CD8(+) T cells is a rate-limiting step in the process of islet allograft rejection.
引用
收藏
页码:247 / 255
页数:9
相关论文
共 62 条
[1]   Islet rejection in perforin-deficient mice - The role of perforin and fas [J].
Ahmed, KR ;
Guo, TB ;
Gaal, KK .
TRANSPLANTATION, 1997, 63 (07) :951-957
[2]   Perforin-independent β-cell destruction by diabetogenic CD8+ T lymphocytes in transgenic nonobese diabetic mice [J].
Amrani, A ;
Verdaguer, J ;
Anderson, B ;
Utsugi, T ;
Bou, S ;
Santamaria, P .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (08) :1201-1209
[3]   Cellular responses to interferon-gamma [J].
Boehm, U ;
Klamp, T ;
Groot, M ;
Howard, JC .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :749-795
[4]   The role of Fas in autoimmune diabetes [J].
Chervonsky, AV ;
Wang, Y ;
Wong, FS ;
Visintin, I ;
Flavell, RA ;
Janeway, CA ;
Matis, LA .
CELL, 1997, 89 (01) :17-24
[5]   2 TYPES OF MOUSE HELPER T-CELL CLONE .3. FURTHER DIFFERENCES IN LYMPHOKINE SYNTHESIS BETWEEN TH1 AND TH2 CLONES REVEALED BY RNA HYBRIDIZATION, FUNCTIONALLY MONOSPECIFIC BIOASSAYS, AND MONOCLONAL-ANTIBODIES [J].
CHERWINSKI, HM ;
SCHUMACHER, JH ;
BROWN, KD ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1229-1244
[6]  
Coulombe M, 1996, J IMMUNOL, V157, P4790
[7]  
Coulombe M, 1999, J IMMUNOL, V162, P2503
[8]  
Dellacasagrande J, 1999, J IMMUNOL, V162, P2259
[9]   ISLET ALLOGRAFT, ISLET XENOGRAFT, AND SKIN ALLOGRAFT SURVIVAL IN CD8+ T-LYMPHOCYTE DEFICIENT MICE [J].
DESAI, NM ;
BASSIRI, H ;
KIM, J ;
KOLLER, BH ;
SMITHIES, O ;
BARKER, CF ;
NAJI, A ;
MARKMANN, JF ;
AUCHINCLOSS .
TRANSPLANTATION, 1993, 55 (04) :718-722
[10]  
GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245